ADA_ETA_BIO2021: Real-World Evaluation of Adherence, Persistence, and Cost-Effectiveness of Originator and Biosimilar Biologic Drugs in the Treatment of Rheumatoid Arthritis: a Multicenter Study in Italy.

Fiorenzo Santoleri,Ruggero Lasala,Paolo Abrate, Laura Pestrin,Enrico Pasut, Germana Modesti,Felice Musicco,Chiara Fulgenzio, Eva Zuzolo,Gabriella Pieri,Martina Roperti, Pietro Gazzola,Marco Gambera, Isabella Martignoni, Valentina Montresor,Francesco De Vita, Francesca Guarino, Laura Grossi,Letizia Di Fabio, Cristina Roberti, Concetta Spoltore, Gabriella Tinari, Stefania De Rosa, Romina Giannini,Roberto Langella,Grazia Mingolla, Mariantonietta Piccoli,Alberto Costantini

CURRENT MEDICAL RESEARCH AND OPINION（2023）

Cited 0|Views10

Key words

Rheumatoid arthritis,bDMARDs,Adherence to treatment,Persistence,Cost-effectiveness

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined